The Nexus of Endocrine Signaling and Cancer: How Steroid Hormones Influence Genomic Stability
Open Access
- 1 December 2020
- journal article
- review article
- Published by The Endocrine Society in Endocrinology
- Vol. 162 (1)
Abstract
Endocrine-driven malignancies, including breast and prostate cancer, are among the most common human cancers. The relationship between sex steroid hormones (eg, androgen, estrogen, and progesterone), their cognate receptors, and genomic stability lie at the center of endocrine-driven cancer development, progression, and therapeutic resistance. A variety of direct and indirect mechanisms have been described that link steroid hormone signaling to the loss of genomic integrity that drives early carcinogenesis. These effects are often enriched within endocrine receptor cistromes, accounting for the high proportion of mutations and rearrangements in the region of hormone response elements. In other cases, the effects are generalized and rely on a complex array of genetic, epigenetic, and metabolic interactions. Both androgen and estrogen receptors directly modulate the DNA damage response by trans-activating DNA damage response genes and redirecting the cellular repair machinery in the wake of genotoxic stress. Here we review the key mechanistic underpinnings of the relationship between sex steroid hormone receptors and genomic stability. In addition, we summarize emerging research in this area and discuss important implications for cancer prevention and treatment.Keywords
Funding Information
- U.S. Department of War (W81XWH-18-1-0177, W81XWH-19-PRCRP-TTSA)
- American Cancer Society (134805-RSG-20-070-01-TBG)
- National Institutes of Health
- National Cancer Institute (L30 CA220908)
- VeloSano Foundation
- National Comprehensive Cancer Network Foundation
This publication has 92 references indexed in Scilit:
- PARP Inhibition Sensitizes to Low Dose-Rate Radiation TMPRSS2-ERG Fusion Gene-Expressing and PTEN-Deficient Prostate Cancer CellsPLOS ONE, 2013
- Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancerNature Genetics, 2012
- Cyclin D1 Is a Selective Modifier of Androgen-dependent Signaling and Androgen Receptor FunctionJournal of Biological Chemistry, 2011
- The MRN complex in double‐strand break repair and telomere maintenanceFEBS Letters, 2010
- Androgen-induced TOP2B-mediated double-strand breaks and prostate cancer gene rearrangementsNature Genetics, 2010
- Nuclear Receptor-Induced Chromosomal Proximity and DNA Breaks Underlie Specific Translocations in CancerCell, 2009
- The DNA-damage response in human biology and diseaseNature, 2009
- Estrogen Inhibits ATR Signaling to Cell Cycle Checkpoints and DNA RepairMolecular Biology of the Cell, 2009
- A novel androgen receptor-binding element modulates Cdc6 transcription in prostate cancer cells during cell-cycle progressionNucleic Acids Research, 2009
- Recurrent gene fusions in prostate cancerNature Reviews Cancer, 2008